Jim Cramer on Verve Therapeutics Inc. (VERV): 'I Think It's A Winner'

By Yahoo! Finance | Sep 20, 2024 at 03:05 AM EST

Jim Cramer's Top 12 Must-Watch Stocks feature Verve Therapeutics Inc. (NASDAQ:VERV) for its innovative gene-editing technology targeting cardiovascular diseases. With strong leadership and promising clinical trials, VERV holds potential for growth in the health sector.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.